Phototoxicity Potential of 6% Bemotrizinol

Clinical trial NCT05254925 · COMPLETED

Trial details

NCT number: NCT05254925
Sponsor: dsm-firmenich Switzerland AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Phototoxic Response

Start date: 2022-02-28
Primary completion: 2022-03-03
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.